Sensitive ASX Announcement

FDA Orphan Drug Designation for Bone Marrow Conditioning

Published: 29/03/22, 11:05am (AEST)2 pages
Telix Pharmaceuticals Limited
TLX:ASXHealthcare

Recent TLX Announcements

Price Sensitive only